Search research articles
Contact Us
Filters
Showing results (151-160 of 389) with videos related to
Page
of 39
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 13, 2008
High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c
Marianne Kyndi, Marie Overgaard, Hanne M Nielsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 2, 2011
Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance
Filippo P D'Andrea, Akmal Safwat, Moustapha Kassem, et al.
BMC Cancer
|
April 23, 2015
Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients
Henry Jensen, Marie Louise Tørring, Frede Olesen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 27, 2020
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity
Mette Saksø, Kenneth Jensen, Maria Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2008
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group
Marianne Kyndi, Flemming B Sørensen, Helle Knudsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 14, 2009
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
Pernille Lassen, Jesper Grau Eriksen, Stephen Hamilton-Dutoit, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 26, 2025
BiGART 2025 - the 25th Acta Oncologica Symposium
Jens Overgaard, Morten Høyer, Birgitte Vrou Offersen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 29, 2015
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study
Jens Bentzen, Kasper Toustrup, Jesper Grau Eriksen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
March 31, 2016
Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study
Henry Jensen, Marie Louise Tørring, Morten Fenger-Grøn, et al.
The British Journal of Oral & Maxillofacial Surgery
|
December 1, 2009
Randomised controlled trials in HBO: "A call to arms" for HOPON & DAHANCA-21
Richard Shaw, Lone Forner, Chris Butterworth, et al.
Page
of 39
Search research articles
Search
Showing results (151-160 of 389) with videos related to
Sort By:
Page
of 39
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 13, 2008
High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c
Marianne Kyndi, Marie Overgaard, Hanne M Nielsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 2, 2011
Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance
Filippo P D'Andrea, Akmal Safwat, Moustapha Kassem, et al.
BMC Cancer
|
April 23, 2015
Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients
Henry Jensen, Marie Louise Tørring, Frede Olesen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 27, 2020
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity
Mette Saksø, Kenneth Jensen, Maria Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2008
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group
Marianne Kyndi, Flemming B Sørensen, Helle Knudsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 14, 2009
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
Pernille Lassen, Jesper Grau Eriksen, Stephen Hamilton-Dutoit, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 26, 2025
BiGART 2025 - the 25th Acta Oncologica Symposium
Jens Overgaard, Morten Høyer, Birgitte Vrou Offersen, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 29, 2015
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study
Jens Bentzen, Kasper Toustrup, Jesper Grau Eriksen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
March 31, 2016
Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study
Henry Jensen, Marie Louise Tørring, Morten Fenger-Grøn, et al.
The British Journal of Oral & Maxillofacial Surgery
|
December 1, 2009
Randomised controlled trials in HBO: "A call to arms" for HOPON & DAHANCA-21
Richard Shaw, Lone Forner, Chris Butterworth, et al.
Page
of 39